High dose methotrexate with and without BCG therapy in advanced head and neck malignancy
暂无分享,去创建一个
[1] J. Bertino. "Rescue" techniques in cancer chemotherapy: use of leucovorin and other rescue agents after methotrexate treatment. , 1977, Seminars in oncology.
[2] J. Sullivan,et al. HIGH‐DOSE METHOTREXATE THERAPY , 1977, The Medical journal of Australia.
[3] A. Ketcham,et al. High dose methotrexate as a preoperative adjuvant in the treatment of epidermoid carcinoma of the head and neck. A feasibility study and clinical trial. , 1975, American journal of surgery.
[4] R. Donaldson. Chemoimmunotherapy for cancer of the head and neck. , 1973, American journal of surgery.
[5] J. Bertino,et al. Improved therapeutic index of methotrexate with "leucovorin rescue". , 1973, Cancer research.
[6] R. Donaldson. Methotrexate plus Bacillus Calmette-Guérin (BCG) and isoniazid in the treatment of cancer of the head and neck. , 1972, American journal of surgery.
[7] M. Friedman,et al. Treatment of squamous cell carcinoma of the head and neck with combined methotrexate and irradiation , 1970, Cancer.
[8] J. Bertino,et al. Methotrexate therapy of head and neck cancer: improvement in therapeutic index by the use of leucovorin "rescue". , 1970, Cancer research.
[9] J. Bertino,et al. Effectiveness of high-dose infusions of methotrexate followed by leucovorin in carcinoma of the head and neck. , 1968, Cancer research.
[10] J. Bertino,et al. Head and neck cancer. 3. Toxicity of 24-hour infusions of methotrexate (NSC-740) and protection by leucovorin (NSC-3590) in patients with epidermoid carcinomas. , 1967, Cancer chemotherapy reports.
[11] N. Mantel,et al. Eradication Of Leukaemic Cells (L1210) by Methotrexate and Methotrexate Plus Citrovorum Factor , 1966, Nature.